Cameron is a registered Australian and New Zealand Patent Attorney with extensive experience in managing International patent portfolios in the Biotechnology space. Regular counsel is provided to clients in relation to strategic planning, due diligence and patentability advice with clients ranging from publicly listed biotechnology companies to smaller ‘start-up’ companies and university commercialisation teams. Counsel is primarily sought after in relation to diagnostics and biological therapeutics such as antibodies and stem cells.
Holding a bachelor of Biotechnology (honours), a PhD in molecular biology and a Masters in Commercial Law, Cameron is equally comfortable working directly with boards, leadership teams or in-house counsel, having demonstrated the motivation, interpersonal skills and knowledge required to work effectively across different levels and areas of an organisation.
PhD research focused on a class of small RNA molecules known as microRNA’s. Studies investigated the role of microRNA’s in an upper gastrointestinal disease sequence characterised by its systematic progression from gastroesophageal reflux disease (GORD) to Barrett’s oesophagus and oesophageal cancer. Research projects focused on investigating microRNA mediated mechanisms for cancer development, in addition to characterising microRNAs as useful diagnostic and prognostic biomarkers.
Honours research investigated neuronal changes that occur during chronic heart failure development and how these changes might be targeted to slow or arrest the progression of this disease. During his honours year, Cameron also won the Nick McClure Prize in Enterprise Management, graduating top of his class in a course designed to develop the skills required for the commercialisation of technology via a ‘start-up’ biotechnology company.
Cameron is also actively involved in intellectual property education, providing regular talks to assist organisations with raising awareness of intellectual property and developing intellectual property strategy.